elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Pricing
Log in
Sign up
Home
/
Subjects
/
Somatostatin
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Keyword
keyword
Somatostatin
RIS
0.002
(Research Intensity Score)
Papers
293
Top papers
Consensus on acromegaly therapeutic outcomes: an update
2025 · 69 citations
EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor- and PSMA-targeting ligands
2022 · 249 citations
Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standards for diagnostics and therapy (theranostics) of meningiomas using radiolabeled somatostatin receptor ligands: version 1.0
2024 · 66 citations
Consensus on molecular imaging and theranostics in neuroendocrine neoplasms
2021 · 248 citations
Radiomics and Artificial Intelligence in Radiotheranostics: A Review of Applications for Radioligands Targeting Somatostatin Receptors and Prostate-Specific Membrane Antigens
2024 · 54 citations
First-in-human administration of terbium-161-labelled somatostatin receptor subtype 2 antagonist ([161Tb]Tb-DOTA-LM3) in a patient with a metastatic neuroendocrine tumour of the ileum
2024 · 43 citations
[ 177 Lu]Lu-DOTA-TATE in newly diagnosed patients with advanced grade 2 and grade 3, well-differentiated gastroenteropancreatic neuroendocrine tumors: Primary analysis of the phase 3 randomized NETTER-2 study.
2024 · 45 citations
Somatostatin and Mannooligosaccharide Modified Selenium Nanoparticles with Dual-Targeting for Ulcerative Colitis Treatment
2025 · 21 citations
177 Lu-DOTATATE in Combination with PARP Inhibitor Olaparib Is Feasible in Patients with Somatostatin-Positive Tumors: Results from the LuPARP Phase I Trial
2025 · 21 citations
Newest papers
Peptide receptor radionuclide therapy in neuroendocrine tumours: advances, combination strategies, and future directions
2026 · 4 citations
Changes in Outcomes of Hepatic Cytoreduction for Neuroendocrine Liver Metastases over Two Decades: From Major Hepatectomy to Parenchyma-Sparing Approaches
2026
[161Tb]Tb-DOTATATE as a potential treatment option for neuroblastoma
2026
[161Tb]Tb-DOTATATE as a potential treatment option for neuroblastoma
2026
Radiolabeling and physicochemical characterization of terbium-161 DOTATATE
2026
[161Tb]Tb-DOTATATE as a potential treatment option for neuroblastoma
2026
Mo1830 A MACHINE LEARNING MODEL TO PREDICT RESPONSE TO RADIOLIGAND THERAPY IN PATIENTS WITH ADVANCED GASTROENTEROPANCREATIC NEUROENDOCRINE NEOPLASMS PROGRESSIVE AFTER SOMATOSTATIN ANALOGS
2026
Mo1830 A MACHINE LEARNING MODEL TO PREDICT RESPONSE TO RADIOLIGAND THERAPY IN PATIENTS WITH ADVANCED GASTROENTEROPANCREATIC NEUROENDOCRINE NEOPLASMS PROGRESSIVE AFTER SOMATOSTATIN ANALOGS
2026
Intra-Arterial Radioligand Therapy in Brain Cancer: Bridging Nuclear Medicine and Interventional Neuroradiology
2026 · 1 citations
Browse all papers →
Somatostatin's history
Research intensity over time
Yearly
Personal members see monthly resolution →
Data temporarily unavailable — please try again shortly.
Close ✕
Somatostatin's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link